Abstract
Myocardial ischaemia resulting from obstructive coronary artery disease is a major cause of morbidity and mortality in the developed world. Coronary artery bypass graft (CABG) surgery is the gold-standard treatment in many patients with complex multivessel coronary artery disease or left main disease. Despite substantial improvements in the outcome of patients undergoing CABG surgery in the past decade, graft patency remains the ‘Achilles’ heel’ of this procedure. Whereas the use of the left internal mammary artery as a conduit is associated with the highest 10-year patency rate (>90%), saphenous vein grafts — the most commonly used conduit in CABG surgery — fail in 40−50% of treated patients by 10 years after surgery. Vein graft disease (VGD) and failure result from complex pathophysiological processes that can lead to complete occlusion of the graft, affecting long-term clinical outcomes. Optimal harvesting techniques, intraoperative preservation strategies and intraoperative patency control have important roles in the prevention of VGD. In addition, several studies published in the past decade have reported similar mid-term patency rates between vein grafts and arterial grafts when veins are used as a composite graft based on the internal mammary artery. In this Review, we present the latest evidence on the utilization of saphenous vein grafts for CABG surgery and provide an overview of the current practices for the prevention of VGD and vein graft failure.
Key points
-
Saphenous vein grafts (SVGs) are the most frequently used conduits for coronary artery bypass graft (CABG) surgery but are associated with 10-year vein graft failure (VGF) rates of 40−50%.
-
Endothelial damage attributable to mechanical harm and ischaemia–reperfusion injury contribute to the development of vein graft damage (VGD) and VGF, which are mediated by thrombosis, intimal hyperplasia and atherosclerosis in the early, intermediate and late phases, respectively.
-
Prevention of VGD and VGF requires a meticulous harvesting strategy (either open, no-touch or endoscopic) to reduce surgical trauma and avoid excessive handling and distension.
-
Optimized intraoperative preservation of SVGs to maintain normal endothelial function and integrity of the SVG during harvest can reduce the occurrence of VGD and VGF.
-
Traditional intraoperative preservation solutions, such as saline or autologous whole blood, cannot sufficiently preserve the endothelium and might even be harmful to SVGs.
-
Intraoperative graft flow assessment is important in identifying grafts that have initial low flow and can provide an opportunity to correct the issue intraoperatively.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Benjamin, E. J. et al. Heart disease and stroke statistics-2017 update: a report from the American Heart Association. Circulation 135, e146–e603 (2017).
Riley, R. F., Don, C. W., Powell, W., Maynard, C. & Dean, L. S. Trends in coronary revascularization in the United States from 2001 to 2009: recent declines in percutaneous coronary intervention volumes. Circ. Cardiovasc. Qual. Outcomes 4, 193–197 (2011).
Fihn, S. D. et al. 2014 ACC/AHA/AATS/PCNA/SCAI/STS focused update of the guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines, and the American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J. Am. Coll. Cardiol. 64, 1929–1949 (2014).
Neumann, F. J. et al. 2018 ESC/EACTS Guidelines on myocardial revascularization. Eur. Heart J. 40, 87–165 (2019).
Arsalan, M. & Mack, M. J. Coronary artery bypass grafting is currently underutilized. Circulation 133, 1036–1045 (2016).
Carrel, A. VIII. On the experimental surgery of the thoracic aorta and heart. Ann. Surg. 52, 83–95 (1910).
Sones, F. M. Jr. & Shirey, E. K. Cine coronary arteriography. Mod. Concepts Cardiovasc. Dis. 31, 735–738 (1962).
Vineberg, A. M. Development of an anastomosis between the coronary vessels and a transplanted internal mammary artery. Can. Med. Assoc. J. 55, 117–119 (1946).
Murray, G., Porcheron, R., Hilario, J. & Roschlau, W. Anastomosis of systemic artery to the coronary. Can. Med. Assoc. J. 71, 594–597 (1954).
Goetz, R. H., Rohman, M., Haller, J. D., Dee, R. & Rosenak, S. S. Internal mammary-coronary artery anastomosis. A nonsuture method employing tantalum rings. J. Thorac. Cardiovasc. Surg. 41, 378–386 (1961).
Murray, G., Hilario, J., Porcheron, R. & Roschlau, W. Surgery of coronary heart disease. Angiology 4, 526–531 (1953).
Sabiston, D. C., Jr. The William F. Rienhoff, Jr. lecture. The coronary circulation. Johns Hopkins Med. J. 134, 314–329 (1974).
Olearchyk, A. S. Vasili I. Kolesov. A pioneer of coronary revascularization by internal mammary-coronary artery grafting. J. Thorac. Cardiovasc. Surg. 96, 13–18 (1988).
Kolesov, V. I. & Potashov, L. V. [Surgery of coronary arteries]. Eksp. Khir. Anesteziol. 10, 3–8 (1965).
Kolessov, V. I. Mammary artery-coronary artery anastomosis as method of treatment for angina pectoris. J. Thorac. Cardiovasc. Surg. 54, 535–544 (1967).
Favaloro, R. G. Saphenous vein autograft replacement of severe segmental coronary artery occlusion: operative technique. Ann. Thorac. Surg. 5, 334–339 (1968).
Favaloro, R. G., Effler, D. B., Groves, L. K., Fergusson, D. J. & Lozada, J. S. Double internal mammary artery-myocardial implantation. Clinical evaluation of results in 150 patients. Circulation 37, 549–555 (1968).
Favaloro, R. G. Critical analysis of coronary artery bypass graft surgery: a 30-year journey. J. Am. Coll. Cardiol. 31, 1b–63b (1998).
Buffolo, E., Andrade, J. C., Succi, J., Leao, L. E. & Gallucci, C. Direct myocardial revascularization without cardiopulmonary bypass. Thorac. Cardiovasc. Surg. 33, 26–29 (1985).
Benetti, F. J. Direct coronary surgery with saphenous vein bypass without either cardiopulmonary bypass or cardiac arrest. J. Cardiovasc. Surg. 26, 217–222 (1985).
Borst, C. et al. Coronary artery bypass grafting without cardiopulmonary bypass and without interruption of native coronary flow using a novel anastomosis site restraining device (“Octopus”). J. Am. Coll. Cardiol. 27, 1356–1364 (1996).
Benetti, F. J., Naselli, G., Wood, M. & Geffner, L. Direct myocardial revascularization without extracorporeal circulation. Experience in 700 patients. Chest 100, 312–316 (1991).
Holzhey, D. M. et al. Seven-year follow-up after minimally invasive direct coronary artery bypass: experience with more than 1300 patients. Ann. Thorac. Surg. 83, 108–114 (2007).
Calafiore, A. M. et al. Left anterior descending coronary artery grafting via left anterior small thoracotomy without cardiopulmonary bypass. Ann. Thorac. Surg. 61, 1658–1663; discussion 1664-1655 (1996).
Srivastava, S., Barrera, R. & Quismundo, S. One hundred sixty-four consecutive beating heart totally endoscopic coronary artery bypass cases without intraoperative conversion. Ann. Thorac. Surg. 94, 1463–1468 (2012).
Authors/Task Force members. et al. 2014 ESC/EACTS Guidelines on myocardial revascularization: the Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur. Heart J. 35, 2541–2619 (2014).
Hillis, L. D. et al. 2011 ACCF/AHA guideline for coronary artery bypass graft surgery: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 124, e652–e735 (2011).
Aldea, G. S. et al. The Society of Thoracic Surgeons Clinical practice guidelines on arterial conduits for coronary artery bypass grafting. Ann. Thorac. Surg. 101, 801–809 (2016).
Gaudino, M. et al. Radial artery as a coronary artery bypass conduit: 20-year results. J. Am. Coll. Cardiol. 68, 603–610 (2016).
Muneretto, C. et al. Total arterial myocardial revascularization with composite grafts improves results of coronary surgery in elderly: a prospective randomized comparison with conventional coronary artery bypass surgery. Circulation 108, II29–II33 (2003).
Ruttmann, E. et al. Second internal thoracic artery versus radial artery in coronary artery bypass grafting: a long-term, propensity score-matched follow-up study. Circulation 124, 1321–1329 (2011).
Head, S. J. et al. Coronary artery bypass grafting: part 2 – optimizing outcomes and future prospects. Eur. Heart J. 34, 2873–2886 (2013).
Taggart, D. P. ART – randomised comparison of bilateral versus single internal thoracic coronary artery bypass graft surgery: effects on mortality at ten years follow-up in the Arterial Revascularisation Trial (ART) (FP no. 2320). Presented at the ESC Congress 2018, (2018).
Taggart, D. P. et al. Randomized trial of bilateral versus single internal-thoracic-artery grafts. N. Engl. J. Med. 375, 2540–2549 (2016).
Benedetto, U. et al. Pedicled and skeletonized single and bilateral internal thoracic artery grafts and the incidence of sternal wound complications: insights from the arterial revascularization trial. J. Thorac. Cardiovasc. Surg. 152, 270–276 (2016).
D’Agostino, R. S. et al. The Society of Thoracic Surgeons Adult Cardiac Surgery Database: 2018 update on outcomes and quality. Ann. Thorac. Surg. 105, 15–23 (2018).
Falk, V. Coronary bypass grafting with bilateral internal thoracic arteries. Heart 99, 821 (2013).
Schwann, T. A. et al. Operative outcomes of multiple-arterial versus single-arterial coronary bypass grafting. Ann. Thorac. Surg. 105, 1109–1119 (2018).
US National Library of Medicine. ClinicalTrials.gov https://clinicaltrials.gov/ct2/show/NCT03217006. (2019).
Hess, C. N. et al. Saphenous vein graft failure after coronary artery bypass surgery: insights from PREVENT IV. Circulation 130, 1445–1451 (2014).
Fitzgibbon, G. M. et al. Coronary bypass graft fate and patient outcome: angiographic follow-up of 5,065 grafts related to survival and reoperation in 1,388 patients during 25 years. J. Am. Coll. Cardiol. 28, 616–626 (1996).
Goldman, S. et al. Long-term patency of saphenous vein and left internal mammary artery grafts after coronary artery bypass surgery: results from a Department of Veterans Affairs cooperative study. J. Am. Coll. Cardiol. 44, 2149–2156 (2004).
Motwani, J. G. & Topol, E. J. Aortocoronary saphenous vein graft disease: pathogenesis, predisposition, and prevention. Circulation 97, 916–931 (1998).
Parang, P. & Arora, R. Coronary vein graft disease: pathogenesis and prevention. Can. J. Cardiol. 25, e57–e62 (2009).
Gaudino, M. F. L., Spadaccio, C. & Taggart, D. P. State-of-the-art coronary artery bypass grafting: patient selection, graft selection, and optimizing outcomes. Interv. Cardiol. Clin. 8, 173–198 (2019).
Deo, S. V. et al. Bilateral internal thoracic artery harvest and deep sternal wound infection in diabetic patients. Ann. Thorac. Surg. 95, 862–869 (2013).
de Vries, M. R., Simons, K. H., Jukema, J. W., Braun, J. & Quax, P. H. Vein graft failure: from pathophysiology to clinical outcomes. Nat. Rev. Cardiol. 13, 451–470 (2016).
Harskamp, R. E., Lopes, R. D., Baisden, C. E., de Winter, R. J. & Alexander, J. H. Saphenous vein graft failure after coronary artery bypass surgery: pathophysiology, management, and future directions. Ann. Surg. 257, 824–833 (2013).
Cheung-Flynn, J. et al. Limiting injury during saphenous vein graft preparation for coronary arterial bypass prevents metabolic decompensation. Sci. Rep. 7, 14179 (2017).
Osgood, M. J. et al. Surgical vein graft preparation promotes cellular dysfunction, oxidative stress, and intimal hyperplasia in human saphenous vein. J. Vasc. Surg. 60, 202–211 (2014).
Jeremy, J. Y., Rowe, D., Emsley, A. M. & Newby, A. C. Nitric oxide and the proliferation of vascular smooth muscle cells. Cardiovasc. Res. 43, 580–594 (1999).
Owens, C. D. Adaptive changes in autogenous vein grafts for arterial reconstruction: clinical implications. J. Vasc. Surg. 51, 736–746 (2010).
Muto, A., Model, L., Ziegler, K., Eghbalieh, S. D. D. & Dardik, A. Mechanisms of vein graft adaptation to the arterial circulation: insights into the neointimal algorithm and management strategies. Circ. J. 74, 1501–1512 (2010).
Sugimoto, M., Yamanouchi, D. & Komori, K. Therapeutic approach against intimal hyperplasia of vein grafts through endothelial nitric oxide synthase/nitric oxide (eNOS/NO) and the Rho/Rho-kinase pathway. Surg. Today 39, 459–465 (2009).
Weaver, H., Shukla, N., Ellinsworth, D. & Jeremy, J. Y. Oxidative stress and vein graft failure: a focus on NADH oxidase, nitric oxide and eicosanoids. Curr. Opin. Pharmacol. 12, 160–165 (2012).
Moreno, K. et al. Circulating inflammatory cells are associated with vein graft stenosis. J. Vasc. Surg. 54, 1124–1130 (2011).
Wezel, A. et al. Complement factor C5a induces atherosclerotic plaque disruptions. J. Cell. Mol. Med. 18, 2020–2030 (2014).
Yazdani, S. K. et al. Pathology of drug-eluting versus bare metal stents in saphenous vein bypass graft lesions. JACC. Cardiovasc. interv. 5, 666–674 (2012).
Yahagi, K. et al. Pathophysiology of native coronary, vein graft, and in-stent atherosclerosis. Nat. Rev. Cardiol. 13, 79 (2015).
Brown, E. N. et al. Thinking inside the graft: applications of optical coherence tomography in coronary artery bypass grafting. J. Biomed. Opt. 12, 051704 (2007).
Burris, N. S. et al. Optical coherence tomography imaging as a quality assurance tool for evaluating endoscopic harvest of the radial artery. Ann. Thorac. Surg. 85, 1271–1277 (2008).
Kiani, S. et al. Endoscopic venous harvesting by inexperienced operators compromises venous graft remodeling. Ann. Thorac. Surg. 93, 11–18 (2012).
Perrault, L. P. et al. Techniques, complications, and pitfalls of endoscopic saphenectomy for coronary artery bypass grafting surgery. J. Card. Surg. 20, 393–402 (2005).
Allen, K. et al. Endoscopic vascular harvest in coronary artery bypass grafting surgery: a consensus statement of the International Society of Minimally Invasive Cardiothoracic Surgery (ISMICS) 2005. Innovations 1, 51–60 (2005).
Williams, J. B. et al. Association between endoscopic vs open vein-graft harvesting and mortality, wound complications, and cardiovascular events in patients undergoing CABG surgery. JAMA 308, 475–484 (2012).
Lumsden, A. B., Eaves, F. F., Ofenloch, J. C. & Jordan, W. D. Subcutaneous, video-assisted saphenous vein harvest: report of the first 30 cases. Cardiovasc. Surg. 4, 771–776 (1996).
Dacey, L. J. Endoscopic vein-graft harvest is safe for CABG surgery. JAMA 308, 512–513 (2012).
Cadwallader, R. A. et al. Great saphenous vein harvesting: a systematic review and meta-analysis of open versus endoscopic techniques. Vasc. Endovasc. Surg. 43, 561–566 (2009).
Lopes, R. D. et al. Endoscopic versus open vein-graft harvesting in coronary-artery bypass surgery. New Engl. J. Med. 361, 235–244 (2009).
Zenati, M. A. et al. Impact of endoscopic versus open saphenous vein harvest technique on late coronary artery bypass grafting patient outcomes in the ROOBY (Randomized On/Off Bypass) Trial. J. Thorac. Cardiovasc. Surg. 141, 338–344 (2011).
Dacey, L. J. et al. Long-term outcomes of endoscopic vein harvesting after coronary artery bypass grafting. Circulation 123, 147–153 (2011).
Deppe, A. C. et al. Endoscopic vein harvesting for coronary artery bypass grafting: a systematic review with meta-analysis of 27,789 patients. J. Surg. Res. 180, 114–124 (2013).
Grant, S. W. et al. What is the impact of endoscopic vein harvesting on clinical outcomes following coronary artery bypass graft surgery? Heart 98, 60–64 (2012).
Sastry, P. et al. The influence of endoscopic vein harvesting on outcomes after coronary bypass grafting: a meta-analysis of 267 525 patients. Eur. J. Cardiothorac. Surg. 44, 980–989 (2013).
Zenati, M. A. et al. Randomized trial of endoscopic or open vein-graft harvesting for coronary-artery bypass. N. Engl. J. Med. 380, 132–141 (2019).
Johansson, B. L. et al. Slower progression of atherosclerosis in vein grafts harvested with ‘no touch’ technique compared with conventional harvesting technique in coronary artery bypass grafting: an angiographic and intravascular ultrasound study. Eur. J. Cardiothorac. Surg. 38, 414–419 (2010).
Samano, N. et al. The no-touch saphenous vein for coronary artery bypass grafting maintains a patency, after 16 years, comparable to the left internal thoracic artery: a randomized trial. J. Thorac. Cardiovasc. Surg. 150, 880–888 (2015).
Angelini, G. D., Passani, S. L., Breckenridge, I. M. & Newby, A. C. Nature and pressure dependence of damage induced by distension of human saphenous vein coronary artery bypass grafts. Cardiovasc. Res. 21, 902–907 (1987).
Kennedy, J. H., Lever, M. J., Addis, B. J. & Paneth, M. Changes in vein interstitium following distension for aortocoronary bypass. J. Cardiovasc. Surg. 30, 992–995 (1989).
Chung, A. W. et al. Pressure distention compared with pharmacologic relaxation in vein grafting upregulates matrix metalloproteinase-2 and -9. J. Vasc. Surg. 42, 747–756 (2005).
Souza, D. A new no-touch preparation technique: technical notes. Scand. J. Thorac. Cardiovasc. Surg. 30, 41–44 (1996).
Deb, S. et al. SUPERIOR SVG: no touch saphenous harvesting to improve patency following coronary bypass grafting (a multi-centre randomized control trial, NCT01047449). J. Cardiothorac. Surg. 14, 85 (2019).
Perrault, L. P. et al. Early quantitative coronary angiography of saphenous vein grafts for coronary artery bypass grafting harvested by means of open versus endoscopic saphenectomy: a prospective randomized trial. J. Thorac. Cardiovasc. Surg. 127, 1402–1407 (2004).
Yun, K. L. et al. Randomized trial of endoscopic versus open vein harvest for coronary artery bypass grafting: six-month patency rates. J. Thorac. Cardiovasc. Surg. 129, 496–503 (2005).
Favaloro, R. G. Saphenous vein graft in the surgical treatment of coronary artery disease. Operative technique. J. Thorac. Cardiovasc. Surg. 58, 178–185 (1969).
Garrett, H., Dennis, E. W. & DeBakey, M. E. Aortocoronary bypass with saphenous vein graft: seven-year follow-up. JAMA 223, 792–794 (1973).
Mueller, R. L., Rosengart, T. K. & Isom, O. W. The history of surgery for ischemic heart disease. Ann. Thorac. Surg. 63, 869–878 (1997).
Gundry, S. R., Jones, M., Ishihara, T. & Ferrans, V. J. Optimal preparation techniques for human saphenous vein grafts. Surgery 88, 785–794 (1980).
Lawrie, G. M., Weilbacher, D. E. & Henry, P. D. Endothelium-dependent relaxation in human saphenous vein grafts. Effects of preparation and clinicopathologic correlations. J. Thorac. Cardiovasc. Surg. 100, 612–620 (1990).
Lamm, P., Juchem, G., Milz, S. & Reichart, B. Continuous graft perfusion: optimizing the quality of saphenous vein grafts. Heart Surg. Forum 5, S355–S361 (2002).
Zerkowski, H. R. et al. Endothelial damage of the venous graft in CABG. Influence of solutions used for storage and rinsing on endothelial function. Eur. J. Cardiothorac. Surg. 7, 376–382 (1993).
Wilbring, M. et al. Heparinized blood better preserves cellular energy charge and vascular functions of intraoperatively stored saphenous vein grafts in comparison to isotonic sodium-chloride-solution. Clin. Hemorheol. Microcirc. 55, 445–455 (2013).
Catinella, F. P. et al. The factors influencing early patency of coronary artery bypass vein grafts: correlation of angiographic and ultrastructural findings. J. Thorac. Cardiovasc. Surg. 83, 686–700 (1982).
Santoli, E. et al. University of Wisconsin solution and human saphenous vein graft preservation: preliminary anatomic report. Eur. J. Cardiothorac. Surg. 7, 548–552 (1993).
Chester, A. H., O’Neil, G. S., Tadjakarimi, S., Borland, J. A. & Yacoub, M. H. Effect of peri-operative storage solution on the vascular reactivity of the human saphenous vein. Eur. J. Cardiothorac. Surg. 7, 399–404 (1993).
Winkler, B. et al. Graft preservation solutions in cardiovascular surgery. Interact. Cardiovasc. Thorac. Surg. 23, 300–309 (2016).
Baumann, F. G., Catinella, F. P., Cunningham, J. N. Jr. & Spencer, F. C. Vein contraction and smooth muscle cell extensions as causes of endothelial damage during graft preparation. Ann. Surg. 194, 199–211 (1981).
Rizoli, S. PlasmaLyte. J. Trauma 70, S17–S18 (2011).
Cavallari, N. et al. Functional and morphological evaluation of canine veins following preservation in different storage media. J. Surg. Res. 68, 106–115 (1997).
Hickethier, T., Dammrich, J., Silber, R. E., Finster, S. & Elert, O. Ultrastructural investigations for reducing endothelial cell damage of vein grafts during CABG-operation and practical consequences. J. Cardiovasc. Surg. 40, 71–76 (1999).
Roubos, N., Rosenfeldt, F. L., Richards, S. M., Conyers, R. A. & Davis, B. B. Improved preservation of saphenous vein grafts by the use of glyceryl trinitrate-verapamil solution during harvesting. Circulation 92, II31–II36 (1995).
Wilbring, M. et al. Even short-time storage in physiological saline solution impairs endothelial vascular function of saphenous vein grafts. Eur. J. Cardiothorac. Surg. 40, 811–815 (2011).
Wille, T., de Groot, H. & Rauen, U. Improvement of the cold storage of blood vessels with a vascular preservation solution. Study in porcine aortic segments. J. Vasc. Surg. 47, 422–431 (2008).
Zatschler, B. et al. Improved vessel preservation after 4 days of cold storage: experimental study in rat arteries. J. Vasc. Surg. 50, 397–406 (2009).
Veres, G. et al. TiProtec preserves endothelial function in a rat model. J. Surg. Res. 200, 346–355 (2016).
Wilbring, M. et al. Preservation of endothelial vascular function of saphenous vein grafts after long-time storage with a recently developed potassium-chloride and N-acetylhistidine enriched storage solution. Thorac. Cardiovasc. Surg. 61, 656–662 (2013).
Alexander, J. H. et al. Efficacy and safety of edifoligide, an E2F transcription factor decoy, for prevention of vein graft failure following coronary artery bypass graft surgery: PREVENT IV: a randomized controlled trial. JAMA 294, 2446–2454 (2005).
Harskamp, R. E. et al. Vein graft preservation solutions, patency, and outcomes after coronary artery bypass graft surgery: follow-up from the PREVENT IV randomized clinical trial. JAMA Surg. 149, 798–805 (2014).
Thatte, H. S. et al. Multi-photon microscopic evaluation of saphenous vein endothelium and its preservation with a new solution, GALA. Ann. Thorac. Surg. 75, 1145–1152 (2003).
Haime, M. et al. Relationship between intra-operative vein graft treatment with DuraGraft® or saline and clinical outcomes after coronary artery bypass grafting. Expert Rev. Cardiovasc. Ther. 16, 963–970 (2018).
Ben Ali, W. et al. DuraGraft vascular conduit preservation solution in patients undergoing coronary artery bypass grafting: rationale and design of a within-patient randomised multicentre trial. Open Heart 5, e000780 (2018).
US National Library of Medicine. ClinicalTrials.gov https://clinicaltrials.gov/ct2/show/NCT02272582 (2018).
US National Library of Medicine. ClinicalTrials.gov https://clinicaltrials.gov/ct2/show/NCT02774824 (2018).
Emmert, M. et al. TCT-284 DuraGraft, a one-time intraoperative treatment against vein graft failure: a randomized multicenter trial using longitudinal MDCT angiography analysis in patients undergoing CABG. J. Am. Coll. Cardiol. 70, B116–B117 (2017).
US National Library of Medicine. ClinicalTrials.gov https://clinicaltrials.gov/ct2/show/NCT02922088 (2018).
Calafiore, A. M. et al. Bilateral internal thoracic artery grafting: long-term clinical and angiographic results of in situ versus Y grafts. J. Thorac. Cardiovasc. Surg. 120, 990–998 (2000).
Hwang, H. Y., Cho, K. R. & Kim, K.-B. Equivalency of right internal thoracic artery and right gastroepiploic artery composite grafts: five-year outcomes. Ann. Thorac. Surg. 96, 2061–2068 (2013).
Gaudino, M. et al. Composite Y internal thoracic artery-saphenous vein grafts: short-term angiographic results and vasoreactive profile. J. Thorac. Cardiovasc. Surg. 127, 1139–1144 (2004).
Glineur, D. et al. Comparison of fractional flow reserve of composite Y-grafts with saphenous vein or right internal thoracic arteries. J. Thorac. Cardiovasc. Surg. 140, 639–645 (2010).
Hwang, H. Y., Lee, K. H., Han, J. W. & Kim, K. B. Equivalency of saphenous vein and arterial composite grafts: 5-year angiography and midterm clinical follow-up. Ann. Thorac. Surg. 102, 580–588 (2016).
Kim, M.-S. et al. Saphenous vein versus right internal thoracic artery as a Y-composite graft: five-year angiographic and clinical results of a randomized trial. J. Thorac. Cardiovasc. Surg. 156, 1424–1433.e1421 (2018).
Kim, Y. H., Oh, H. C., Choi, J. W., Hwang, H. Y. & Kim, K. B. No-touch saphenous vein harvesting may improve further the patency of saphenous vein composite grafts: early outcomes and 1-year angiographic results. Ann. Thorac. Surg. 103, 1489–1497 (2017).
Kieser, T. M., Rose, S., Kowalewski, R. & Belenkie, I. Transit-time flow predicts outcomes in coronary artery bypass graft patients: a series of 1000 consecutive arterial grafts. Eur. J. Cardiothorac. Surg. 38, 155–162 (2010).
Kieser, T. M. Graft quality verification in coronary artery bypass graft surgery: how, when and why? Curr. Opin. Cardiol. 32, 722–736 (2017).
Wolf, R. K. & Falk, V. Intraoperative assessment of coronary artery bypass grafts. J. Thorac. Cardiovasc. Surg. 126, 634–637 (2003).
Gaudino, M. et al. Mechanisms, consequences, and prevention of coronary graft failure. Circulation 136, 1749–1764 (2017).
Souza, D. S. et al. Improved patency in vein grafts harvested with surrounding tissue: results of a randomized study using three harvesting techniques. Ann. Thorac. Surg. 73, 1189–1195 (2002).
Kulik, A. et al. Secondary prevention after coronary artery bypass graft surgery: a scientific statement from the American Heart Association. Circulation 131, 927–964 (2015).
Deo, S. V. et al. Dual anti-platelet therapy after coronary artery bypass grafting: is there any benefit? A systematic review and meta-analysis. J. Cardiac Surg. 28, 109–116 (2013).
Zhao, Q. et al. Effect of ticagrelor plus aspirin, ticagrelor alone, or aspirin alone on saphenous vein graft patency 1 year after coronary artery bypass grafting: a randomized clinical trial. JAMA 319, 1677–1686 (2018).
Parsonnet, V., Lari, A. A. & Shah, I. H. New stent for support of veins in arterial grafts. Arch. Surg. 87, 696–702 (1963).
Genoni, M., Odavic, D., Loblein, H. & Dzemali, O. Use of the eSVS mesh: external vein support does not negatively impact early graft patency. Innovations 8, 211–214 (2013).
Inderbitzin, D. T. et al. One-year patency control and risk analysis of eSVS(®)-mesh-supported coronary saphenous vein grafts. J. Cardiothorac. Surg. 10, 108 (2015).
Rescigno, G. et al. Saphenous vein graft wrapping by nitinol mesh: a word of caution. Thorac. Cardiovasc. Surg. 63, 292–297 (2015).
Taggart, D. P. et al. A randomized trial of external stenting for saphenous vein grafts in coronary artery bypass grafting. Ann. Thorac. Surg. 99, 2039–2045 (2015).
Taggart, D. P. et al. Long-term performance of an external stent for saphenous vein grafts: the VEST IV trial. J. Cardiothorac. Surg. 13, 117 (2018).
US National Library of Medicine. ClinicalTrials.gov https://clinicaltrials.gov/ct2/show/NCT02511834 (2019).
Yi, G., Shine, B., Rehman, S. M., Altman, D. G. & Taggart, D. P. Effect of bilateral internal mammary artery grafts on long-term survival: a meta-analysis approach. Circulation 130, 539–545 (2014).
Locker, C. et al. Multiple arterial grafts improve late survival of patients undergoing coronary artery bypass graft surgery: analysis of 8622 patients with multivessel disease. Circulation 126, 1023–1030 (2012).
Benedetto, U. et al. Searching for the second best graft for coronary artery bypass surgery: a network meta-analysis of randomized controlled trials. Eur. J. Cardiothorac. Surg. 47, 59-65; discussion 65 (2015).
Stone, G. W. et al. Everolimus-eluting stents or bypass surgery for left main coronary artery disease. N. Engl. J. Med. 375, 2223–2235 (2016).
Mäkikallio, T. et al. Percutaneous coronary angioplasty versus coronary artery bypass grafting in treatment of unprotected left main stenosis (NOBLE): a prospective, randomised, open-label, non-inferiority trial. Lancet 388, 2743–2752 (2016).
Park, S. J. et al. Trial of everolimus-eluting stents or bypass surgery for coronary disease. N. Engl. J. Med. 372, 1204–1212 (2015).
Ahn, J. M. et al. Randomized trial of stents versus bypass surgery for left main coronary artery disease: 5-year outcomes of the PRECOMBAT study. J. Am. Coll. Cardiol. 65, 2198–2206 (2015).
Mohr, F. W. et al. Coronary artery bypass graft surgery versus percutaneous coronary intervention in patients with three-vessel disease and left main coronary disease: 5-year follow-up of the randomised, clinical SYNTAX trial. Lancet 381, 629–638 (2013).
Farkouh, M. E. et al. Strategies for multivessel revascularization in patients with diabetes. N. Engl. J. Med. 367, 2375–2384 (2012).
Velazquez, E. J. et al. Coronary-artery bypass surgery in patients with left ventricular dysfunction. N. Engl. J. Med. 364, 1607–1616 (2011).
Velazquez, E. J. et al. Coronary-artery bypass surgery in patients with ischemic cardiomyopathy. N. Engl. J. Med. 374, 1511–1520 (2016).
Taggart, D. P. et al. Bilateral versus single internal-thoracic-artery grafts at 10 years. N. Engl. J. Med. 380, 437–446 (2019).
Hayward, P. A. et al. Comparable patencies of the radial artery and right internal thoracic artery or saphenous vein beyond 5 years: results from the Radial Artery Patency and Clinical Outcomes trial. J. Thorac. Cardiovasc. Surg. 139, 60-65; discussion 65-67 (2010).
Desai, N. D., Cohen, E. A., Naylor, C. D., Fremes, S. E. & Radial Artery Patency Study Investigators. A randomized comparison of radial-artery and saphenous-vein coronary bypass grafts. N. Engl. J. Med. 351, 2302–2309 (2004).
Deb, S. et al. Radial artery and saphenous vein patency more than 5 years after coronary artery bypass surgery: results from RAPS (radial artery patency study). J. Am. Coll. Cardiol. 60, 28–35 (2012).
Lamy, A. et al. Five-year outcomes after off-pump or on-pump coronary-artery bypass grafting. N. Engl. J. Med. 375, 2359–2368 (2016).
Diegeler, A. et al. Five-year outcome after off-pump or on-pump coronary artery bypass grafting in elderly patients. Circulation 139, 1865–1871 (2019).
Krishnamoorthy, B. et al. Study comparing vein integrity and clinical outcomes in open vein harvesting and 2 types of endoscopic vein harvesting for coronary artery bypass grafting: the VICO Randomized Clinical Trial (Vein Integrity and Clinical Outcomes). Circulation 136, 1688–1702 (2017).
Author information
Authors and Affiliations
Contributions
E.C. and M.Y.E. researched the data for the article and wrote the manuscript. All the authors made substantial contributions to discussion of content and reviewed/edited the manuscript before submission.
Corresponding author
Ethics declarations
Competing interests
E.C., A.B. and Y.-H.C. are investigators in the European VASC registry and members of the registry scientific advisory board. C.M.G. has received consultancy fees from Somahlution. L.P.P. is a member of the VASC registry scientific advisory board and has received consultancy fees from Somahlution. M.Y.E. is the principal investigator of the VASC registry and the chair of the registry scientific advisory board, and has received consulting fees from Maquet and Somahlution. The other authors declare no competing interests.
Additional information
Peer review information
Nature Reviews Cardiology thanks T. Kieser, S. Raja and the other, anonymous, reviewer(s) for their contribution to the peer review of this work.
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Glossary
- Vineberg procedure
-
Direct implantation of the left internal mammary artery on the anterior myocardial wall for treatment of angina.
- Payr’s ring
-
A device of two interlocking rings facilitating non-sutured anastomosis of vessels.
- Cardiopulmonary bypass
-
(CPB). An extracorporeal circuit in which venous blood is drained, oxygenated and pumped back to the circulatory system to provide circulatory and respiratory function.
- Off-pump CABG surgery
-
Performing coronary artery bypass graft surgery without the aid of cardiopulmonary bypass on a non-arrested, beating heart.
- Octopus stabilizer
-
Local tissue stabilizer to facilitate off-pump coronary artery bypass graft procedures.
- Totally endoscopic coronary bypass surgery
-
Procedure performed through four to five fingertip-sized portholes as a closed-chest procedure with the aid of robotic telemanipulation systems.
- Vein graft failure
-
(VGF). Complete occlusion of a saphenous vein graft as a result of complex pathophysiological processes.
- Autologous whole blood
-
(AWB). Blood with all components obtained from the patient during surgery.
- Scanning electron microscopy
-
(SEM). Focused beam of high-energy electrons generating signals at the surface of a solid specimen.
- PlasmaLyte
-
A family of balanced crystalloid solutions with multiple different formulations closely mimicking human plasma in pH, osmolality and electrolyte content.
- Bretschneider’s cardioplegic solution
-
Also known as HTK or Custodiol solution. A cardioplegic solution with the main ingredients of histidine, tryptophan and ketoglutarate.
- Ringer’s crystalloid solution
-
A crystalloid solution containing Na+, K+, Ca2+ and Cl− with a pH of 6.5.
- University of Wisconsin solution
-
(UWS). A preservation solution that mimics the ionic composition of intracellular fluids and contains antioxidants and high-molecular-weight molecules; the gold-standard solution for preservation of abdominal organs.
- TiProtec
-
A dedicated storage solution enriched in potassium chloride and N-acetylhistidine.
- GALA solution
-
A dedicated preservation, storage and flushing solution for vascular conduits; works as an endothelium-damage inhibitor and contains reduced glutathione, l-ascorbic acid and l-arginine.
- Multidetector computed tomography (MDCT) angiography
-
Angiography based on CT technology with a 2D array of detector elements.
Rights and permissions
About this article
Cite this article
Caliskan, E., de Souza, D.R., Böning, A. et al. Saphenous vein grafts in contemporary coronary artery bypass graft surgery. Nat Rev Cardiol 17, 155–169 (2020). https://doi.org/10.1038/s41569-019-0249-3
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41569-019-0249-3
This article is cited by
-
Lymphedema after saphenous harvesting for coronary artery bypass surgery: case report and literature review
BMC Cardiovascular Disorders (2024)
-
Identification of important genes related to HVSMC proliferation and migration in graft restenosis based on WGCNA
Scientific Reports (2024)
-
Prognostic assessment of coronary artery bypass patients based on coronary CTA: vessel weight and native artery lesions aid in predicting cardiovascular events
Chinese Journal of Academic Radiology (2024)
-
Mechanobiology of the endothelium in vascular health and disease: in vitro shear stress models
Cardiovascular Drugs and Therapy (2023)
-
Editorial comment on “current practice of saphenous vein graft harvesting in coronary artery bypass graft surgery: an Indian survey”
Indian Journal of Thoracic and Cardiovascular Surgery (2023)